Clinical Trial Update: Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Fudan University evaluating probiotics with concurrent hyperfractionated chemoradiotherapy and maintenance with the PD-1 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Probiotics

Snippet

Sponsor: Fudan University | Conditions: Limited Stage Small Cell Lung Cancer | Phase 2 | Status: RECRUITING